Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6402905rdf:typepubmed:Citationlld:pubmed
pubmed-article:6402905lifeskim:mentionsumls-concept:C0027651lld:lifeskim
pubmed-article:6402905lifeskim:mentionsumls-concept:C0039144lld:lifeskim
pubmed-article:6402905lifeskim:mentionsumls-concept:C0025869lld:lifeskim
pubmed-article:6402905lifeskim:mentionsumls-concept:C0175668lld:lifeskim
pubmed-article:6402905lifeskim:mentionsumls-concept:C0205421lld:lifeskim
pubmed-article:6402905lifeskim:mentionsumls-concept:C2349975lld:lifeskim
pubmed-article:6402905lifeskim:mentionsumls-concept:C1627358lld:lifeskim
pubmed-article:6402905pubmed:issue1lld:pubmed
pubmed-article:6402905pubmed:dateCreated1983-4-7lld:pubmed
pubmed-article:6402905pubmed:abstractTextSix cases of syringomyelia associated with intramedullary tumor were examined by metrizamide myelography and delayed computed tomography. All cases showed opacification of syringomyelic cavities 7-24 hr after myelography. This finding suggests that metrizamide can pass through the cord substance from the subarachnoid space into a syrinx cavity in noncommunicating types of syringomyelia. It supports the theory of transneural passage of fluid as part of the origin of such cavities. These cases also support the thesis that, in patients with cord cavities, tumor can be excluded only if the cavity is demonstrated within all areas of cord enlargement.lld:pubmed
pubmed-article:6402905pubmed:languageenglld:pubmed
pubmed-article:6402905pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6402905pubmed:citationSubsetIMlld:pubmed
pubmed-article:6402905pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6402905pubmed:statusMEDLINElld:pubmed
pubmed-article:6402905pubmed:issn0195-6108lld:pubmed
pubmed-article:6402905pubmed:authorpubmed-author:BarnettH JHJlld:pubmed
pubmed-article:6402905pubmed:authorpubmed-author:FoxA JAJlld:pubmed
pubmed-article:6402905pubmed:authorpubmed-author:KanSSlld:pubmed
pubmed-article:6402905pubmed:authorpubmed-author:PeerlessS JSJlld:pubmed
pubmed-article:6402905pubmed:authorpubmed-author:ViñuelaFFlld:pubmed
pubmed-article:6402905pubmed:issnTypePrintlld:pubmed
pubmed-article:6402905pubmed:volume4lld:pubmed
pubmed-article:6402905pubmed:ownerNLMlld:pubmed
pubmed-article:6402905pubmed:authorsCompleteYlld:pubmed
pubmed-article:6402905pubmed:pagination73-8lld:pubmed
pubmed-article:6402905pubmed:dateRevised2008-2-14lld:pubmed
pubmed-article:6402905pubmed:meshHeadingpubmed-meshheading:6402905-...lld:pubmed
pubmed-article:6402905pubmed:meshHeadingpubmed-meshheading:6402905-...lld:pubmed
pubmed-article:6402905pubmed:meshHeadingpubmed-meshheading:6402905-...lld:pubmed
pubmed-article:6402905pubmed:meshHeadingpubmed-meshheading:6402905-...lld:pubmed
pubmed-article:6402905pubmed:meshHeadingpubmed-meshheading:6402905-...lld:pubmed
pubmed-article:6402905pubmed:meshHeadingpubmed-meshheading:6402905-...lld:pubmed
pubmed-article:6402905pubmed:meshHeadingpubmed-meshheading:6402905-...lld:pubmed
pubmed-article:6402905pubmed:meshHeadingpubmed-meshheading:6402905-...lld:pubmed
pubmed-article:6402905pubmed:meshHeadingpubmed-meshheading:6402905-...lld:pubmed
pubmed-article:6402905pubmed:meshHeadingpubmed-meshheading:6402905-...lld:pubmed
pubmed-article:6402905pubmed:meshHeadingpubmed-meshheading:6402905-...lld:pubmed
pubmed-article:6402905pubmed:articleTitleDelayed CT metrizamide enhancement of syringomyelia secondary to tumor.lld:pubmed
pubmed-article:6402905pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6402905pubmed:publicationTypeCase Reportslld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6402905lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6402905lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6402905lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6402905lld:pubmed